US90386H4048 - LYRIX (XNAS)
Lyrical U.S. Value Equity Fund Institutional Class Fonds
No Price
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | 0,00 % | 0,00 % | 0,91 % | 6,50 % | 58,40 % |
Company Profile for Lyrical U.S. Value Equity Fund Institutional Class Fonds
The fund invests principally in a diversified portfolio of common stock of mid-capitalization and large-capitalization companies with low valuations relative to their long-term normalized earnings. It normally invests at least 80% of its net assets plus the amount of any borrowings for investment purposes in common stocks traded on a United States securities exchange.
Company Data to Lyrical U.S. Value Equity Fund Institutional Class Fonds
Name Lyrical U.S. Value Equity Fund Institutional Class
Company Lyrical U.S. Value Equity Fund Institutional Class
Symbol LYRIX
Primary Exchange
NASDAQ
ISIN US90386H4048
Asset Class Fonds
Sector Financial Services
Industry Asset Management
Market Capitalization 892 Mio
Country United States of America
Currency USD
Employees -
Address ULTIMUS MANAGERS TRUST(LYRICAL),
IPO Date 2013-02-04
Dividends from 'Lyrical U.S. Value Equity Fund Institutional Class'
Ex-Date | Dividend per Share |
---|---|
28.12.2023 | 0,10 USD |
29.12.2022 | 0,08 USD |
30.12.2021 | 0,03 USD |
30.12.2020 | 0,14 USD |
30.12.2019 | 0,05 USD |
29.11.2019 | 0,40 USD |
28.12.2018 | 0,05 USD |
30.11.2018 | 1,38 USD |
29.12.2017 | 0,004 USD |
30.11.2017 | 1,29 USD |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | LYRIX |
More Shares
Investors who Lyrical U.S. Value Equity Fund Institutional Class hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.